Pediatr. praxi. 2017;18(1):56-58 | DOI: 10.36290/ped.2017.011

The rare case of boy with diagnosis LAL-D

MUDr. Lenka «oukálková
Dětské oddělení Krajské nemocnice T. Bati, a. s.

Rare storage disease LAL-D (lysosomal acid lipase-deficiency) is an autosomal recesive disorder. Formely it used to be named

Wolman´s disease or CESD (cholesteryl ester storage disease). These two formes differ only by the activity of the coded enzyme,

whose residual activity is responsible for the gravity of the symptoms and the time of their occurence. There was no effective

therapy antill recently. But this has changed and ERT (enzyme replacement therapy) with acid lipase is the new perspective.

Diagnostic markers are:

1. Dyslipidemia, high total cholesterol, high LDL cholesterol, low HDL cholesterol, triglycerides are not elevated in all the cases.

2. Hepatopathia, increased liver enzymes, hepatomegaly, steatosis, hepatofibrosis, or cirhosis of the unknow origin.

The case description shows that though the correct and quick diagnosis may be difficult it opens the way to the very effective

therapy of this progressive disease causing severe morbidity and premature mortality.

Keywords: LAL-D, CESD, acid lipase, storage disease, hypercholesterolemia

Published: April 4, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
«oukálková L. The rare case of boy with diagnosis LAL-D. Pediatr. praxi. 2017;18(1):56-58. doi: 10.36290/ped.2017.011.
Download citation

References

  1. Mazurová S, Poupětová H, et al. Nemoc ze střádání esterů cholesterolu (CESD): Klinická, laboratorní a histologická charakteristika ąesti pacientů. Čes-slov Pediat 2014; 69(3): 148-160.
  2. Agostino D, et al. Cholesteryl ester storage disease: clinical, biochemical and pathological studies of four new cases. J Pediatr Gastroenterol Nutr 1988; 7(3): 446-450. Go to original source... Go to PubMed...
  3. Smolka V. Hepatomegalie v dětském věku. Pediatrie pro praxi 2001; 5: 229-232.
  4. Drebber U, Andesen M, Kasper Hu, et al. Severe chronic diarrhoea and Weight loss in choleresterol ester storage dinase: a case report. World J Gastroenterol 2005; 11: 2364-2366. Go to original source... Go to PubMed...
  5. Smolka V. Nemoc ze střádání esterů cholesterolu - efekt dlouhodobé léčby lovastatinem. Čes a Slov Gastroent a Hepatol 2007; 61(1): 30-33.
  6. Valayannopoulos V, et al. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patiens with lysosomal acid lipase deficiency. J Hepatol. 2014; 61: 1135-1142. Go to original source... Go to PubMed...
  7. Du H, et al. Molecular and enzymatic analyses of lysozomal acid lipase in cholesteryl ester storage disease. Mol Genet Metab 1988; 64(2): 126-134. Go to original source... Go to PubMed...
  8. Elleder M, Poupětová H, Ledvinová J, et al. Deficit kyselé (lysozomální) lipazy: přehled českých pacientů. Čas Lék Čes 1999; 138: 719-724.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.